NCT03977207View on ClinicalTrials.gov

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

NARecruitingINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Thyroid; Functional DisturbanceHypothyroidismHemodialysis
Interventions
DRUG

Levothyroxine Sodium

Thyroid hormone supplement

DRUG

Placebos

Placebo oral capsule

Trial Locations (1)

92868

RECRUITING

University of California Irvine, Orange

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Irvine

OTHER